• Xunfei Healthcare plans to reallocate HK$ 32.3 million of H Share Global Offering proceeds from acquisitions to research and development.
• The proposed shift requires shareholder approval, with the reallocated funds expected to be fully utilized by the end of June 2027.
• Spending will strengthen algorithms and machine learning capabilities, supported by research hiring, technology infrastructure investment and external research partnerships.
• No suitable acquisition targets have been identified; future acquisitions would use internal or self-raised funds.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Xunfei Healthcare Technology Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261023-12382044), on October 23, 2026, and is solely responsible for the information contained therein.